Associate Professor of Medicine, Washington University School of Medicine
Oncology
Dr. Geoffrey L. Uy, MD
|
|
Give Review
Geoffrey is an expert in the field of Oncology. He went to Washington University School of Medicine in St. Louis. He has 1 awards "CMS Meaningful Use Stage 1 Certification". Dr. Geoffrey L. Uy is a published doctor. He has 35 publications published. The most current publication "The Drosophila grapes gene is related to checkpoint gene chk1/rad27 and is required for late syncytial division fidelity." He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies.
- Targeting CD123 in AML using a T-Cell directed dual-affinity re-targeting (DART®) platform.
- Genomic analysis of germline and somatic variants in familial myelodysplasia/Acute myeloid leukemia.
- A phase II study of V-BEAM as conditioning regimen before second auto-SCT for multiple Myeloma.
- Haploidentical transplantation using G-CSF-mobilized T-Cell replete PBSCs and post-transplantation CY after non-myeloablative conditioning is safe and is associated wi...
- A phase I dose escalation study of oral bexarotene in combination with intravenous decitabine in patients with AML.
- Phase I study of cladribine, cytarabine, granulocyte colony stimulating factor (CLAG regimen) and midostaurin and all-trans retinoic acid in relapsed/refractory AML.
- Phase I study of oral clofarabine consolidation in adults aged 60 and older with Acute myeloid leukemia.
- Effect of post remission therapy prior to reduced intensity conditioning allogeneic transplantation for Acute myeloid leukemia in first complete remission.
- Protective Effect of Cytomegalovirus Reactivation on Relapse after Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia Patients Is Influenced by Co...
- Dual receptor T cells mediate pathologic alloreactivity in patients with Acute graft-versus-host disease.
- A phase 1 study of concomitant high-dose lenalidomide and 5-azacitidine induction in the treatment of AML.
- Expression and function of PML-RARA in the hematopoietic progenitor Cells of Ctsg-PML-RARA mice.
- Plasmacytoma-like post-transplantation lymphoproliferative disease occurring in a cardiac alloGraft: a case report and review of the literature.
- Prognostic significance of FDG-PET in relapsed or refractory classical Hodgkin Lymphoma treated with standard salvage chemotherapy and autologous stem cell transplanta...
- Sequencing a mouse Acute promyelocytic leukemia genome reveals genetic events relevant for disease progression.
- A phase 2 study of high-dose lenalidomide as initial therapy for older patients with Acute myeloid leukemia.
- A protease-resistant PML-RAR{alpha} has increased leukemogenic potential in a murine model of Acute promyelocytic leukemia.
- Salvage therapy for Acute myeloid leukemia with fludarabine, cytarabine, and idarubicin with or without gemtuzumab ozogamicin and with concurrent or sequential G-CSF.
- A phase II study of 5-day intravenous azacitidine in patients with Myelodysplastic syndromes.
- BIO5192, a small molecule inhibitor of VLA-4, mobilizes hematopoietic stem and progenitor Cells.
- Chemosensitization of Acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100.
- Impact of mobilization and remobilization strategies on achieving sufficient stem Cell yields for autologous transplantation.
- Bortezomib inhibits osteoclast activity in patients with multiple Myeloma.
- Management of the advanced phases of chronic myelogenous Leukemia in the era of tyrosine kinase inhibitors.
- Plerixafor.
- Plerixafor, a CXCR4 antagonist for the mobilization of hematopoietic stem Cells.
- The activity and toxicity of low dose clofarabine against relapsed or refractory Myeloma.
- Bortezomib administered pre-auto-SCT and as maintenance therapy post transplant for multiple Myeloma: a single institution phase II study.
- Limited enGraftment of low-risk myelodysplastic syndrome cells in NOD/SCID gamma-C chain knockout mice.
- Allo-SCT conditioning for myelodysplastic syndrome and Acute myeloid leukemia with clofarabine, cytarabine and ATG.
- Localization of human Cdc25C is regulated both by nuclear export and 14-3-3 protein binding.
- Exhaled nitric oxide correlates with experimental Lung transplant rejection.
- The Drosophila grapes gene is related to checkpoint gene chk1/rad27 and is required for late syncytial division fidelity.
Schools
Washington Center School of Medicine
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- American Republic
- Anthem Blue Cross Blue Shield PPO
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- CoreSource
- Health and Life PPO
- Coventry Health Care of Missouri PPO
- First Health (Coventry Health Care) PPO
- HealthLink PPO
- HealthPartners
- Homestate Health Plan
- Choice Care PPO
- Medicare MCR
- Medico
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Washington University -
Washington University - Barnes-Jewish Hospital -
Washington University School of Medicine in St. Louis
Hospital
-
Barnes-Jewish Hospital
Drug Facts
| NPI NUMBER | 1750427480 | |
| NPPES Provider LastName | UY | |
| NPPES Provider FirstName | GEOFFREY | |
| NPPES Provider ZIPCode | 631101032 | |
| NPPES Provider State | MO | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 727.0 | |
| Distinct Opioid Count | 4.0 | |
| Opioid Claim Count | 89.0 | |
| Percent Opioid Claims | 12.24 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1750427480 |
| Last Name Of The Provider | UY |
| First Name Of The Provider | GEOFFREY |
| View All |
Similar Doctors
|
|
Dr. Nancy L. Bartlett, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Timothy P. Rearden, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Camille N. Abboud, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Douglas R. Adkins, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amanda Cashen, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Rudolph R. Yanuck III, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Burton M. Needles, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven M. Sorscher, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Marianna B. Ruzinova, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rama Suresh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gerald P. Linette, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Loren S. Michel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maria Q. Baggstrom, MD
This Doctor is OpenDoctor Recommended.
|